The FDA-approved tools for prostate cancer detection include prostate-specific antigen (PSA) blood test, histologic analysis of prostate biopsy using Gleason score, imaging and ultrasound tests, and an expression array of group of cell cycle, DNA repair and breast cancer (BRCA) genes [17]. Here, KLK3 is linked to prostate carcinoma.